BIO REFERENCE LABORATORIES INC Increase (Decrease) in Accounts Payable and Accrued Liabilities
BIO REFERENCE LABORATORIES INC reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $1.91 million for the 6-month period ending 2015-04-30, per its 10-Q filed 2015-06-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2015-06-09
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-04-30 was -$615.00K, a 284.13% decline year-over-year.
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2015-01-31 was $2.52M.
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-10-31 was -$587.00K, a 104.21% decline year-over-year.
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2014-07-31 was $6.79M, a 18.47% increase year-over-year.
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2014 was $3.10M, a 89.15% decline from fiscal 2013.
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2013 was $28.60M, a 244.76% increase from fiscal 2012.
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2012 was $8.30M, a 26.83% increase from fiscal 2011.
- BIO REFERENCE LABORATORIES INC increase (decrease) in accounts payable and accrued liabilities for fiscal 2011 was $6.54M, a 0.47% decline from fiscal 2010.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2015-04-30 | -$615.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-06-09 | $1.91M 10-Q · filed 2015-06-09 | $1.32M derived: sum of 3 quarters · filed 2015-06-09 | $8.11M derived: sum of 4 quarters · filed 2015-06-09 |
| 2015-01-31 | $2.52M 10-Q · filed 2015-03-09 | $1.94M derived: sum of 2 quarters · filed 2015-03-09 | $8.72M derived: sum of 3 quarters · filed 2015-03-09 | $9.06M derived: sum of 4 quarters · filed 2015-06-09 |
| 2014-10-31 | -$587.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-13 | $6.20M derived: sum of 2 quarters · filed 2015-01-13 | $6.53M derived: sum of 3 quarters · filed 2015-06-09 | $3.10M 10-K · filed 2015-01-13 |
| 2014-07-31 | $6.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-04 | $7.12M derived: sum of 2 quarters · filed 2015-06-09 | $3.69M 10-Q · filed 2014-09-04 | $17.64M derived: sum of 4 quarters · filed 2015-06-09 |
| 2014-04-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-06-09 | -$3.10M 10-Q · filed 2015-06-09 | $10.86M derived: sum of 3 quarters · filed 2015-06-09 | $16.59M derived: sum of 4 quarters · filed 2015-06-09 |
| 2014-01-31 | -$3.43M 10-Q · filed 2015-03-09 | $10.52M derived: sum of 2 quarters · filed 2015-03-09 | $16.25M derived: sum of 3 quarters · filed 2015-03-09 | $22.45M derived: sum of 4 quarters · filed 2015-03-09 |
| 2013-10-31 | $13.96M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-13 | $19.68M derived: sum of 2 quarters · filed 2015-01-13 | $25.88M derived: sum of 3 quarters · filed 2015-01-13 | $28.60M 10-K · filed 2015-01-13 |
| 2013-07-31 | $5.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-04 | $11.93M derived: sum of 2 quarters · filed 2014-09-04 | $14.65M 10-Q · filed 2014-09-04 | $21.91M derived: sum of 4 quarters · filed 2015-01-13 |
| 2013-04-30 | $6.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-06 | $8.92M 10-Q · filed 2014-06-06 | $16.19M derived: sum of 3 quarters · filed 2015-01-13 | $15.62M derived: sum of 4 quarters · filed 2015-01-13 |
| 2013-01-31 | $2.72M 10-Q · filed 2014-03-10 | $9.99M derived: sum of 2 quarters · filed 2015-01-13 | $9.42M derived: sum of 3 quarters · filed 2015-01-13 | $9.84M derived: sum of 4 quarters · filed 2015-01-13 |
| 2012-10-31 | $7.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-13 | $6.70M derived: sum of 2 quarters · filed 2015-01-13 | $7.12M derived: sum of 3 quarters · filed 2015-01-13 | $8.30M 10-K · filed 2015-01-13 |
| 2012-07-31 | -$572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-09-06 | -$148.00K derived: sum of 2 quarters · filed 2013-09-06 | $1.03M 10-Q · filed 2013-09-06 | $7.37M derived: sum of 4 quarters · filed 2014-01-13 |
| 2012-04-30 | $424.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-06-07 | $1.60M 10-Q · filed 2013-06-07 | $7.95M derived: sum of 3 quarters · filed 2014-01-13 | $8.53M derived: sum of 4 quarters · filed 2014-01-13 |
| 2012-01-31 | $1.18M 10-Q · filed 2013-03-11 | $7.52M derived: sum of 2 quarters · filed 2014-01-13 | $8.11M derived: sum of 3 quarters · filed 2014-01-13 | $5.55M derived: sum of 4 quarters · filed 2014-01-13 |
| 2011-10-31 | $6.35M derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-13 | $6.93M derived: sum of 2 quarters · filed 2014-01-13 | $4.38M derived: sum of 3 quarters · filed 2014-01-13 | $6.54M 10-K · filed 2014-01-13 |
| 2011-07-31 | $585.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-09-06 | -$1.97M derived: sum of 2 quarters · filed 2012-09-06 | $194.00K 10-Q · filed 2012-09-06 | $4.99M derived: sum of 4 quarters · filed 2013-01-14 |
| 2011-04-30 | -$2.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-06-08 | -$391.00K 10-Q · filed 2012-06-08 | $4.41M derived: sum of 3 quarters · filed 2013-01-14 | |
| 2011-01-31 | $2.16M 10-Q · filed 2012-03-08 | $6.96M derived: sum of 2 quarters · filed 2013-01-14 | ||
| 2010-10-31 | $4.80M derived: 10-K 12 month − 10-Q 9 month · filed 2013-01-14 | $6.57M 10-K · filed 2013-01-14 | ||
| 2010-07-31 | $1.77M 10-Q · filed 2011-09-06 | |||
| 2009-10-31 | $9.58M 10-K · filed 2012-01-13 |